Back
iShares Paris-Aligned Clmt MSCI USA ETF Vs. Astrana Health Industry Stock Comparison
Buy
79
PABU
iShares Paris-Aligned Clmt MSCI USA ETF
Last Price:
65.81
Seasonality Move:
13.32%
Sell
18
ASTH
Astrana Health
Last Price:
42.9200
Seasonality Move:
23.17%
Buy
79
iShares Paris-Aligned Clmt MSCI USA ETF (PABU)
is a Buy
Is iShares Paris-Aligned Clmt MSCI USA ETF a Buy, Sell or Hold?
- The current iShares Paris-Aligned Clmt MSCI USA ETF [PABU] share price is $65.81. The Score for PABU is 79, which is 58% above its historic median score of 50, and infers lower risk than normal.
- PABU is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
18
Astrana Health (ASTH)
is a Sell
Is Astrana Health a Buy, Sell or Hold?
- The current Astrana Health [ASTH] share price is $46.8100. The Score for ASTH is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
- ASTH is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
PABU Stock Price Chart
What is iShares Paris-Aligned Clmt MSCI USA ETF's stock price today?
-
The iShares Paris-Aligned Clmt MSCI USA ETF share price today is $65.81
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PABU is experiencing selling pressure, which indicates risk of future bearish movement.
ASTH Stock Price Chart
What is Astrana Health's stock price today?
-
The Astrana Health share price today is $46.8100
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ASTH is experiencing slight selling pressure.
PABU Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.54 | Buy |
| Relative Strength Index (14 RSI): | 67.8 | Buy |
| Chaikin Money Flow: | -2012 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (63.08 - 64.74) | Buy |
| Bollinger Bands (100): | (59.77 - 63.57) | Buy |
ASTH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.22 | Sell |
| Relative Strength Index (14 RSI): | 31.55 | Sell |
| Chaikin Money Flow: | -120939 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (52.9492 - 60.3292) | Sell |
| Bollinger Bands (100): | (44.5893 - 56.9893) | Sell |
PABU Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 64.11 | Buy |
| 20-day SMA: | 64 | Buy |
| 50-day SMA: | 63.07 | Buy |
| 200-day SMA: | 58.91 | Buy |
| 8-day EMA: | 64.7 | Buy |
| 20-day EMA: | 64.06 | Buy |
| 50-day EMA: | 63.11 | Buy |
| 200-day EMA: | 58.99 | Buy |
ASTH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 53.86 | Sell |
| 20-day SMA: | 56.32 | Sell |
| 50-day SMA: | 55.22 | Sell |
| 200-day SMA: | 45.24 | Buy |
| 8-day EMA: | 52.97 | Sell |
| 20-day EMA: | 55 | Sell |
| 50-day EMA: | 54.44 | Sell |
| 200-day EMA: | 46.93 | Sell |
iShares Paris-Aligned Clmt MSCI USA ETF Earnings Growth & PABU Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Astrana Health Earnings Growth & ASTH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.76 per share, and a decrease next year of $0.13 per share.
iShares Paris-Aligned Clmt MSCI USA ETF Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Astrana Health Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||